Soliqs can offer a variety of analytical tools and services in support of the development of Meltrex and NanoMorph formulations from dissolution, impurity and stability testing at the feasibility stage through to full documentation for regulatory submission. It has particular expertise in the assaying of drug substances which

• are formulated as "solid solutions"
• are formulated as nanoparticles
• exhibit polymorphism

Soliqs also offers a screening system to provide both qualitative and quantitative information on the capability of drug compounds to form solid solutions in different polymers.